Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevnar 13 followed by Pneumovax 23 in HSCT recipients
NCT00980655Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2010
- Primary completion
- May 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 10
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection, sponsored by Pfizer. Started Jan 2010; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00980655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980655.